Caution: For private circulation only.Please note that Money Times is for circulation among paid subscribers only. Any attempt to share your access to our website or forwarding your copy to a non-subscriber will disqualify your membership and we will be compelled to stop your supply and forfeit your subscription thereafter without any refund to you.
Although Money Times recommendation have outperformed other media, stock brokers and research houses, the brief recommendations under Money Times Talk (MTT) cannot display ‘BUY’, ‘SELL’ or ‘HOLD’ recommendations. Readers should, therefore, exercise their own judgement and evaluate the future prospects of the stock given its past performance, industry prospects in the backdrop of a growing economy and in consultation with their investment adviser.
- Alembic Pharma operates in pharmsaceuticals, real estate, and power, trading at an attractive PE of 9. Market cap Rs.2,600 cr; 29% stake in Alembic Pharma valued at Rs.5,000 cr.
- A-1 Ltd has entered a tri-party supply deal for 10,000 MT of Concentrated Nitric Acid with GNFC and Solar Industries, strengthening its industrial chemicals distribution, while also expanding its EV subsidiary A-1 Sureja Industries to support its multi-vertical green growth strategy.
- German MNC, Expleo Solutions posted Q2 EPS of Rs.25.6 and H1 EPS of Rs.38.8, which may lead to FY26 EPS of Rs.72+. The share trades at a P/E of 13.9x vs the industry’s P/E of 38x making it attractively valued.
- Zuari Agro received 6,54,33,846 shares of Paradeep Phosphates valued at Rs.1014.2 cr., which may lead to FY26 EPS of Rs.80 with reserves rising to Rs.2488 cr. vs equity of Rs.42 cr., making it compelling vs peers.
- Brahmaputra Infra posted Q2 EPS of Rs.5 and H1 EPS of Rs.10.2, which may lead to FY26 EPS of Rs.20 from Rs.10.3 in FY25 with a robust medium-to-short term outlook.
